Edwards Lifesciences (EW) EBT (2009 - 2026)

Edwards Lifesciences' EBT history runs 18 years deep, the most recent figure standing at $459.0 million for Q1 2026.

• In Q1 2026, EBT rose 5.78% year-over-year to $459.0 million; the TTM figure through Mar 2026 stood at $1.3 billion (down 19.42% YoY), while the FY2025 annual figure was $1.3 billion, down 17.78% from the prior year.
• EBT was $459.0 million for Q1 2026 at Edwards Lifesciences, up from $90.4 million in the prior quarter.
• In the past five years, EBT ranged from a high of $464.7 million in Q2 2022 to a low of $90.4 million in Q4 2025.
• Historically, EBT has averaged $366.4 million across 5 years, with a median of $390.1 million in 2024.
• The sharpest annual moves came in 2023 and 2025: EBT soared 73.7% in 2023, then tumbled 76.83% in 2025.
• A 5-year view of EBT shows it stood at $211.4 million in 2022, then soared by 73.7% to $367.2 million in 2023, then increased by 6.24% to $390.1 million in 2024, then sank by 76.83% to $90.4 million in 2025, then surged by 407.74% to $459.0 million in 2026.
• The last three EBT figures came in at $459.0 million (Q1 2026), $90.4 million (Q4 2025), and $348.4 million (Q3 2025), per Business Quant data.